M&A Activity • Jul 1, 2025
M&A Activity
Open in ViewerOpens in native device viewer
Munich, July 01, 2025 – Locapharm (former Alcura France), a 100% subsidiary of Mutares SE & Co. KGaA (ISIN: DE000A2NB650), has completed the divestment of its home healthcare services activity in mainland France – referred to as PSAD (Prestations de Santé à Domicile) – to Santé Cie Group, a leading European player of homecare and ambulatory care.
Since December 2024, the management team of the company, supported by operational experts from Mutares, has defined and launched several key measures to carve-out the business from its former shareholder Alliance Healthcare, rebrand it to its historical name Locapharm, focus on its core MAD (maintien à domicile) activities and start the implementation of a build-up strategy with two acquisitions already announced in May and June 2025.
Mutares SE & Co. KGaA, Munich (www.mutares.com), a listed private equity holding company with offices in Munich (HQ), Amsterdam, Bad Wiessee, Chicago, Frankfurt, Helsinki, London, Madrid, Milan, Mumbai, Paris, Shanghai, Stockholm, Vienna and Warsaw, acquires companies in special situations which show significant operational improvement potential and are sold again after undergoing a repositioning and stabilization process.
The shares of Mutares SE & Co. KGaA are traded on the Regulated Market of the Frankfurt Stock Exchange under the symbol "MUX" (ISIN: DE000A2NB650) and are part of the selection index SDAX.
Investor Relations Phone: +49 89 9292 7760 E-mail: [email protected] www.mutares.com
CROSS ALLIANCE communication GmbH Susan Hoffmeister Phone: +49 89 125 09 0333 E-mail: [email protected] www.crossalliance.de
Phone: +33 06 26 59 49 05 E-mail: [email protected] Company News
14:46 Consulting Tom Sutton Phone: +44 7796 474940 E-mail: [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.